1. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome;Abarrategui-Garrido;Blood,2009
2. Allelic variants of complement genes associated with dense deposit disease;Abrera-Abeleda;J. Am. Soc. Nephrol.,2011
3. EHA Presentation. An Orally Administered Small Molecule Factor D Inhibitor (ACH-4471) For Treatment of PNH, C3G and Complement–Mediated Diseases: Interim Phase 1 Results In Healthy Volunteer;Achillion Presentation,2016
4. Achillion Announces Initiation of Patient Dosing in Phase 2 Study of ACH-4471 for Paroxysmal Nocturnal Hemoglobinuria;Achillion Press Release,2017
5. Achillion Reports Third Quarter 2017 Financial Results and Provides Update on Clinical Programs;Achillion Press Release,2017